Exploratory analysis for the evaluation of lopinavir/ritonavir-versus efavirenz-based HAART regimens in antiretroviral-naive HIV-positive patients: results from the Italian MASTER Cohort.
about
Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTIClinical predictors of immune reconstitution following combination antiretroviral therapy in patients from the Australian HIV Observational Database.Lopinavir/r no longer recommended as a first-line regimen: a comparative effectiveness analysis.HIV RNA suppression and immune restoration: can we do better?Efavirenz: a decade of clinical experience in the treatment of HIV.Immunological function restoration with lopinavir/ritonavir versus efavirenz containing regimens in HIV-infected patients: a randomized clinical trialMoving forward with treatment options for HIV-infected children.Interpreting the reasons for the choice and changing of two drug regimens in an observational cohort: comparison of a ritonavir-boosted protease inhibitor-based versus a nonnucleoside reverse transcriptase inhibitor-based first-line regimen.UPLC-MS/MS quantification of nanoformulated ritonavir, indinavir, atazanavir, and efavirenz in mouse serum and tissuesObservational study to evaluate clinical outcomes after first-line efavirenz-or lopinavir-ritonavir-based HAART in treatment-naive patients.Pharmacokinetic and pharmacodynamic analysis of efavirenz dose reduction using an in vitro-in vivo extrapolation model.Effects of first antiretroviral regimen on lipid levels in HIV (+) individuals.CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.Analysis of possible drug-drug interactions between ritonavir and other antiretrovirals in a section of the private health care sector in South Africa.Duration of first-line antiretroviral therapy with tenofovir and emtricitabine combined with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir in the Italian ARCA cohortCohort Profile: Standardized Management of Antiretroviral Therapy Cohort (MASTER Cohort)
P2860
Q33803473-23236468-024B-4A1D-AC6C-09CC8A7D3288Q33933071-ED89B2C1-7C6D-4346-881A-4D4023DCF765Q34251223-CE28FE7A-B014-4EA7-AE45-E81E85A68D0CQ35867173-1F29CE83-31B2-4606-891A-D1A985DF481FQ37383949-EEC942CD-BABF-46D7-9B55-D629CB8A41D1Q39230042-A004EB41-C77F-4CCE-BB04-B779C7C71F0BQ40063042-293E0CE8-0D8A-411B-BB56-14832C8B8BC7Q42229879-19E9FD82-C62D-40B2-B0B8-DF90B5FEC24FQ42844098-19748A6C-738E-4019-9213-F2ADC8B75C43Q43282852-1A682238-C1DD-4D75-A78B-E74E54484D17Q47375821-07AB0917-C0A0-4662-B230-B23AE62BAD42Q47828875-215AA349-4035-4E0C-A200-7D1DF8623911Q53455078-2738AA2D-8EEB-4E6A-864E-9A7DD2F127A0Q55208876-19FCB6A9-B0DC-4C4B-A09A-E096C0125144Q58391347-E4F346D6-3ED7-459C-9786-99188BDBE590Q58485602-876F9DF5-DA0E-42A0-876E-EDF48A2F4501
P2860
Exploratory analysis for the evaluation of lopinavir/ritonavir-versus efavirenz-based HAART regimens in antiretroviral-naive HIV-positive patients: results from the Italian MASTER Cohort.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Exploratory analysis for the e ...... rom the Italian MASTER Cohort.
@en
Exploratory analysis for the e ...... rom the Italian MASTER Cohort.
@nl
type
label
Exploratory analysis for the e ...... rom the Italian MASTER Cohort.
@en
Exploratory analysis for the e ...... rom the Italian MASTER Cohort.
@nl
prefLabel
Exploratory analysis for the e ...... rom the Italian MASTER Cohort.
@en
Exploratory analysis for the e ...... rom the Italian MASTER Cohort.
@nl
P2093
P356
P1476
Exploratory analysis for the e ...... rom the Italian MASTER Cohort.
@en
P2093
Andrea Patroni
Anna Maria Orani
Carlo Torti
Claudio Arici
Franco Maggiolo
Fredy Suter
Giampiero Carosi
Giuseppe Paraninfo
Laura Sighinolfi
Lorenzo Minoli
P304
P356
10.1093/JAC/DKI172
P407
P577
2005-05-25T00:00:00Z